Skip to main content

Outlook Therapeutics, Inc.

OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001649989

In the last 90 days, Outlook Therapeutics, Inc. insiders filed 4 open-market purchases and 0 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $32.5M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Outlook Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
4 filings
4 insiders, $2.60M in total
Open-market sells
0 filings
Insiders trading
4
Net value
+$2.60M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Outlook Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Outlook Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Lundquist Kevin MichaelChief Financial Officer–Sep 2, 20261
Jahr Robert CharlesChief Executive Officer151,515Aug 14, 20262
Sukhtian Ghiath M.Director, 10% Owner24,617,320IndirectAug 14, 20262
GMS Ventures & InvestmentsDirector, 10% Owner24,617,320IndirectAug 14, 20262
Kenyon Lawrence AChief Financial Officer106,956Aug 14, 20262
Sukhtian Faisal GhiathDirector220,972Jul 29, 20263
Haddadin Yezan MuntherDirector66,167Jun 3, 20263
Thurman Randy HDirector5,593May 27, 20262
Hilzinger Kurt JDirector423,655May 27, 20262
Gangolli Julian SDirector–Oct 3, 20251
Auffarth GerdDirector–Oct 3, 20251
Haller Julia ADirector–Oct 3, 20251
Huang AndongDirector–Oct 3, 20251
Syntone Ventures LLC10% Owner1,705,438Apr 17, 20240
Trenary C Russell IIICEO AND PRESIDENT54,925Mar 22, 20240
Evanson JeffCHIEF COMMERCIAL OFFICER808,459Mar 22, 20240
Dagnon TerryChief Operations Officer653,058Apr 21, 20230
BioLexis Pte Ltd.10% Owner22,982,529Apr 22, 20220
Pillai Arun KumarDirector, 10% Owner22,982,529IndirectFeb 1, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 14, 2026 (view filing)8:57 PM ETAug 14Same dayJahr Robert CharlesChief Executive OfficerPPurchase+151.5K––New position151.5K after
Aug 14, 2026 (view filing)8:57 PM ETAug 14Same dayJahr Robert CharlesChief Executive OfficerPPurchase+151.5K–––151.5K afterDerivative
Aug 14, 2026 (view filing)7:52 PM ETAug 122 daysSukhtian Ghiath M. and 1 otherDirector, 10% OwnerPPurchase+2.53M$0.99+$2.50M+11.4%24.6M after
Aug 14, 2026 (view filing)7:52 PM ETAug 122 daysSukhtian Ghiath M. and 1 otherDirector, 10% OwnerPPurchase+2.53M$0.00$0–2.53M afterDerivative
Aug 14, 2026 (view filing)7:39 PM ETAug 14Same dayKenyon Lawrence AChief Financial OfficerPPurchase+101.0K––+1,698.8%107.0K after
Aug 14, 2026 (view filing)7:39 PM ETAug 14Same dayKenyon Lawrence AChief Financial OfficerPPurchase+101.0K–––101.0K afterDerivative
Jul 29, 2026 (view filing)3:19 PM ETJul 29Same daySukhtian Faisal GhiathDirectorPPurchase+95.4K$1.05+$100.0K+76.0%221.0K after
Jun 3, 2026 (view filing)Jun 21 dayHaddadin Yezan MuntherDirectorPPurchase+29.0K$0.83+$24.1K+78.0%66.2K after
Jun 1, 2026 (view filing)9:30 PM ETMay 284 daysSukhtian Ghiath M. and 1 otherDirector, 10% OwnerPPurchase+8.54M$0.5855+$5.00M+63.0%22.1M after
Jun 1, 2026 (view filing)9:30 PM ETMay 284 daysSukhtian Ghiath M. and 1 otherDirector, 10% OwnerPPurchase+15.5M–––8.57M afterDerivative3 lots
May 27, 2026 (view filing)3:29 PM ETMay 27Same daySukhtian Faisal GhiathDirectorPPurchase+122.2K$0.4093+$50.0K+3,593.4%125.6K after
May 27, 2026 (view filing)3:24 PM ETMay 261 dayHaddadin Yezan MuntherDirectorPPurchase+34.0K$0.44+$15.0K+1,073.6%37.2K after
May 27, 2026 (view filing)3:20 PM ETMay 261 dayThurman Randy HDirectorPPurchase+5.00K$0.429+$2.15K+843.2%5.59K after
May 27, 2026 (view filing)3:15 PM ETMay 261 dayHilzinger Kurt JDirectorPPurchase+400.0K$0.4413+$176.5K+1,691.0%423.7K after
Sep 30, 2024 (view filing)Sep 264 daysKenyon Lawrence AChief Financial OfficerPPurchase+5.00K$5.69+$28.4K+528.5%5.95K after
Apr 17, 2024 (view filing)Apr 152 daysSyntone Ventures LLC10% OwnerPPurchase+714.3K––+72.1%1.71M after
Apr 17, 2024 (view filing)Apr 152 daysSyntone Ventures LLC10% OwnerPPurchase+1.07M–––1.07M afterDerivative
Mar 29, 2024 (view filing)Mar 281 dayHaddadin Yezan MuntherDirectorPPurchase+1.88K$11.82+$22.2K+59.4%5.05K after
Mar 11, 2024 (view filing)4:43 PM ETMar 74 daysEvanson JeffCHIEF COMMERCIAL OFFICERPPurchase+62.5K$0.42+$26.2K+8.4%808.5K after
Apr 21, 2023 (view filing)Apr 201 dayDagnon TerryChief Operations OfficerSSale−520.0K$1.14−$592.8K−44.3%653.1K after
Jan 24, 2023 (view filing)Jan 204 daysEvanson JeffChief Commercial OfficerSSale−267.0K$1.11−$296.4K−26.4%746.0K after
Jan 19, 2023 (view filing)Jan 17-192 daysEvanson JeffChief Commercial OfficerSSale−164.2K$1.24−$203.7K−13.9%1.01M after3 lots
Oct 11, 2022 (view filing)Oct 74 daysSukhtian Faisal GhiathDirectorPPurchase+30.0K$1.29+$38.7K+78.9%68.0K after
Oct 11, 2022 (view filing)Oct 6-75 daysHaddadin Yezan MuntherDirectorPPurchase+33.3K$1.29+$42.9K+111.1%63.3K after2 lots
Oct 5, 2022 (view filing)Oct 4-51 dayHilzinger Kurt JDirectorPPurchase+111.2K$1.28+$142.5K+30.7%473.1K after2 lots
Oct 3, 2022 (view filing)Sep 29-Oct 34 daysHilzinger Kurt JDirectorPPurchase+88.8K$1.24+$110.5K+32.5%361.9K after3 lots
Jun 23, 2022 (view filing)Jun 212 daysDagnon TerryChief Operating OfficerPPurchase+10.0K$1.05+$10.5K+0.9%1.17M after
Jun 23, 2022 (view filing)Jun 212 daysTrenary C Russell IIICEO and PresidentPPurchase+19.9K$1.06+$21.1K+56.9%54.9K after
Mar 3, 2022 (view filing)Mar 12 daysHilzinger Kurt JDirectorPPurchase+27.7K$1.69+$46.8K+11.3%273.1K after
Feb 28, 2022 (view filing)Feb 24-284 daysHilzinger Kurt JDirectorPPurchase+47.2K$1.48+$69.7K+23.8%245.4K after2 lots
Feb 23, 2022 (view filing)Feb 22-231 dayHilzinger Kurt JDirectorPPurchase+175.1K$1.47+$257.0K+757.6%198.2K after2 lots
Dec 6, 2021 (view filing)Dec 6Same dayTrenary C Russell IIICEO and PresidentPPurchase+25.0K$1.39+$34.8K+250.0%35.0K after
Dec 6, 2021 (view filing)Dec 6Same dayDagnon TerryChief Operating OfficerPPurchase+25.2K$1.38+$34.8K+2.2%1.16M after
Dec 6, 2021 (view filing)Dec 33 daysEvanson JeffChief Commercial OfficerPPurchase+35.2K$1.34+$47.2K+3.1%1.18M after
Dec 3, 2021 (view filing)Dec 3Same dayDagnon TerryChief Operating OfficerPPurchase+10.0K$1.42+$14.2K+0.9%1.14M after
Dec 2, 2021 (view filing)Dec 2Same dayHaddadin Yezan MuntherDirectorPPurchase+10.0K$1.39+$13.9K+50.0%30.0K after
Dec 2, 2021 (view filing)Dec 2Same daySukhtian Faisal GhiathDirectorPPurchase+18.0K$1.40+$25.2K+90.0%38.0K after
Dec 2, 2021 (view filing)Dec 2Same dayTrenary C Russell IIICEO and PresidentPPurchase+10.0K$1.40+$14.0KNew position10.0K after
Dec 1, 2021 (view filing)7:32 PM ETNov 292 daysSukhtian Ghiath M. and 1 otherDirector, 10% OwnerPPurchase+16.0M$1.25+$20.0M+135.2%27.8M after